#1
PRAXPRAXIS PRECISION MEDICINES I
- Reported value
- $655.97M
- Portfolio weight
- 12.83%
Quarterly change: unchanged
Institutional 13F data
Perceptive Advisors LLC 13F
See 91 stock and ETF positions for Q1 2026, with the original SEC filing. Put and call options are excluded.
13F filing follow-along calculator
If KRW 1,000,000 followed the new and increased positions
Checking current prices and calculating the KRW 1,000,000 result.
Perceptive Advisors LLC 13F top holdings
Q1 2026 · 91 stock & ETF positions · Filed 2026-05-15 · Data updated 2026-06-09
Ranked by quarter-end stock and ETF value reported on Form 13F. Put and call options are excluded. These are not current market values or execution prices.
- Reported stock & ETF value
- $5.09B
- Top 10 concentration
- 51.6%
#2
CELCCELCUITY INC
- Reported value
- $356.94M
- Portfolio weight
- 6.98%
Quarterly change: unchanged
#3
ASNDASCENDIS PHARMA A/S
- Reported value
- $350.28M
- Portfolio weight
- 6.85%
Quarterly change: unchanged
#4
ROIVROIVANT SCIENCES LTD
- Reported value
- $229.51M
- Portfolio weight
- 4.49%
Quarterly change: unchanged
#5
CNTACENTESSA PHARMACEUTICALS PLC
- Reported value
- $208.88M
- Portfolio weight
- 4.09%
Quarterly change: unchanged
#6
RYTMRHYTHM PHARMACEUTICALS INC
- Reported value
- $206.45M
- Portfolio weight
- 4.04%
Quarterly change: unchanged
- Reported value
- $190.83M
- Portfolio weight
- 3.73%
Quarterly change: unchanged
#8
NUVLNUVALENT INC
- Reported value
- $161.92M
- Portfolio weight
- 3.17%
Quarterly change: unchanged
#9
EWTXEDGEWISE THERAPEUTICS INC
- Reported value
- $139.36M
- Portfolio weight
- 2.73%
Quarterly change: unchanged
#10
PTGXPROTAGONIST THERAPEUTICS INC
- Reported value
- $129.73M
- Portfolio weight
- 2.54%
Quarterly change: unchanged
#11
APGEAPOGEE THERAPEUTICS INC
- Reported value
- $129.65M
- Portfolio weight
- 2.54%
Quarterly change: unchanged
#12
TVTXTRAVERE THERAPEUTICS INC
- Reported value
- $123.08M
- Portfolio weight
- 2.41%
Quarterly change: unchanged
Detailed changes for published stocks
2026-03-31 · SYRE · unchanged
- Shares
- 3,783,225
- Share change
- —
- Reported value
- $190,825,869
- Filed
- 2026-05-15